Search for: "Janssen v. Janssen"
Results 261 - 280
of 385
Sorted by Relevance
|
Sort by Date
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
25 Apr 2017, 3:00 am
Baxter International v. [read post]
25 Mar 2009, 5:09 am
Janssen, 426 Pa. [read post]
17 Jul 2017, 5:16 am
Ornamentality v. [read post]
17 Jul 2017, 5:16 am
Ornamentality v. [read post]
13 Aug 2008, 5:00 am
Janssen Pharmaceutica, Inc., No. 07-12259, slip op. (11th Cir. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
5 Aug 2019, 5:00 am
In Janssen v. [read post]
27 Dec 2017, 5:00 am
Janssen Pharmaceuticals, Inc., 2017 Pa. [read post]
16 Jul 2015, 7:25 am
Janssen, 219 Wis. [read post]
5 Jul 2020, 7:58 pm
They concluded that the Deputy Judge’s reliance on Janssen-Ortho Inc. [read post]
4 Jan 2024, 9:42 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
28 May 2015, 6:02 am
Janssen Pharms., Inc., No. 1:14-CV-1025, 2015 U.S. [read post]
6 Feb 2013, 6:28 am
State v. [read post]
2 May 2014, 11:35 am
We knew what the correct result ought to be in Brown v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Ortho Tri-Cyclen Lo (Ethinyl estradiol, norgestimate) – US:Patent infringement complaint filed in New Jersey following a Paragraph IV certification: Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. [read post]
30 May 2017, 5:17 am
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
30 May 2017, 5:17 am
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
23 Apr 2024, 10:28 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
21 Apr 2017, 6:25 am
Brinckerhoff v. [read post]